接受所有 Cookie 可以确保在我们网站上获得良好的用户体验，包括个性化的内容和社交媒体功能。仅接受必要的 Cookie 将在您浏览时使用最少的 Cookie，但是网站上的部分内容可能无法正确显示。如需了解更多信息，请查看我们的 隐私政策。
Big Pharma has long had to contend with rigorous electronic reporting standards, designed to protect patients. Now, it’s the turn of medical device manufacturers, which have so far escaped the same transparency measures. So what does best practice data management and reporting look like? Amplexor’s Elvis Paćelat distils some tips from the pharmaceutical industry’s experiences.
Elvis Paćelat is Vice President Compliance Management at Amplexor Life Sciences. Elvis is a business and technology executive with more than two decades of international experience in the Life Sciences market. With detailed technical understanding and expertise in compliance and regulatory content management solutions for Life Sciences, Elvis is a specialist in business impact analysis. As Amplexor’s VP Compliance Management, he is responsible for driving the corporate strategy and market success of the Amplexor Life Sciences’ suite business. Elvis is committed to delivering benefit for clients, partners and shareholders, whilst supporting client-centric strategies and spearheading groundbreaking innovations.